THE CONGRESS

The 53rd ERA-EDTA Congress has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME).

OFFICIAL WEBSITE:

http://www.era-edta2016.org/en-US/home

FINAL PROGRAMME PDF:

http://www.era-edta2016.org/ERA-EDTA_2016_Final_Programme.pdf

CONGRESS PRESIDENTS

Gert Mayer, Austria Andrzej Więcek, Poland

CONGRESS SECRETARY

Alexander Rosenkranz, Austria

SCIENTIFIC COMMITTEE

Chair: Danilo Fliser, Germany Kerstin Amann, Germany Rosanna Coppo, Italy Olivier Devuyst, Switzerland Kathrin Eller, Austria Jürgen Floege, Germany Denis Fouque, France (also Chairperson of the Paper Selection Committee) Hallvard Holdaas, Norway Faiçal Jarraya, Tunisia Marian Klinger, Poland Mariusz Kusztal, Poland Francesca Mallamaci, Italy Ziad Massy, France Gert Mayer, Austria Alberto Ortiz, Spain Ton Rabelink, The Netherlands Marcus Saemann, Austria Mehmet Sukru Sever, Turkey Rukshana Shroff, United Kingdom Peter Stenvinkel, Sweden Nicholas Topley, United Kingdom Wim Van Biesen, Belgium Andrzej Więcek, Poland Mahmut Yilmaz, Turkey

POSTERS

Posters Posters will be displayed in the Poster Area located in the Exhibition Hall of the Austria Center Vienna. There will be two poster sessions, with the following timetable:

• Sunday, May 22 09:30-10:45
• Monday, May 23 09:30-10:45

EIGHT BEST ABSTRACTS

SO003 RELATIONSHIP BETWEEN MEAN FLUORESCENCE INTENSITY AND C1Q/C3D-FIXING CAPACITIES OF ANTI-HLA ANTIBODIES
Guillaume Claisse, Saint Etienne, France

SO012 PREGNANCY OUTCOMES IN RENAL TRANSPLANT RECIPIENTS IN ENGLAND OVER 15 YEARS
Nadia Sarween, Birmingham, United Kingdom

SO027 IMPROVING THE PREDICTION OF EARLY ANTIBODY MEDIATED REJECTION IN HLA INCOMPATIBLE KIDNEY TRANSPLANTATION
Jorge Malheiro, Porto, Portugal

SO044 PREDICTION MODELS FOR THE MORTALITY RISK IN CHRONIC DIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND INDEPENDENT EXTERNAL VALIDATION STUDY
Chava L. Ramspek, Leiden, The Netherlands

SP642 CANCER INCIDENCE AND PROGRESSION TO MORTALITY AMONG KIDNEY ALLOGRAFT RECIPIENTS IN ENGLAND: A POPULATION-COHORT ANALYSIS BETWEEN 2003 AND 2013
Francesca Jackson-Spence, Birmingham, United Kingdom

MO039 SUCCESSFUL STEROID REPLACEMENT IN ANCA-ASSOCIATED VASCULITIS WITH C5A RECEPTOR INHIBITOR CCX168 IN PHASE 2 RANDOMISED TRIAL (CLEAR)
David Jayne, Cambridge, United Kingdom

MO059 RISK FACTORS FOR SEVERE RENAL DISEASE IN BARDET-BIEDL SYNDROME - PHENOTYPIC AND GENOTYPIC ANALYSES OF THE LARGEST REPORTED AFFECTED COHORT
David J. A. Goldsmith, London, United Kingdom

MP344 THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY
Adriana Dusso, Oviedo, Spain